| Clinical features of neuroendocrine prostate cancer V Conteduca, C Oromendia, KW Eng, R Bareja, M Sigouros, A Molina, ... European journal of cancer 121, 7-18, 2019 | 249 | 2019 |
| A phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: efficacy and biomarkers H Beltran, C Oromendia, DC Danila, B Montgomery, C Hoimes, ... Clinical Cancer Research 25 (1), 43-51, 2019 | 206 | 2019 |
| A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS LE Fredenburgh, MA Perrella, D Barragan-Bradford, DR Hess, E Peters, ... JCI insight 3 (23), 2018 | 90 | 2018 |
| Use of digital rectal examination as an adjunct to prostate specific antigen in the detection of clinically significant prostate cancer JA Halpern, C Oromendia, JE Shoag, S Mittal, MF Cosiano, KV Ballman, ... The Journal of urology 199 (4), 947-953, 2018 | 83 | 2018 |
| Rapidly improving ARDS in therapeutic randomized controlled trials EJ Schenck, C Oromendia, LK Torres, DA Berlin, AMK Choi, II Siempos Chest 155 (3), 474-482, 2019 | 76 | 2019 |
| National trends in management of localized prostate cancer: A population based analysis 2004‐2013 J Chen, C Oromendia, JA Halpern, KV Ballman The Prostate 78 (7), 512-520, 2018 | 61 | 2018 |
| Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS DJ Edwards, M Cortes, A Rykman-Peltz, J Chang, J Elder, G Thickbroom, ... Restorative neurology and neuroscience 37 (2), 167-180, 2019 | 60 | 2019 |
| Alveolar macrophage immunometabolism and lung function impairment in smoking and chronic obstructive pulmonary disease SL O’Beirne, SA Kikkers, C Oromendia, J Salit, MR Rostmai, KV Ballman, ... American journal of respiratory and critical care medicine 201 (6), 735-739, 2020 | 43 | 2020 |
| Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy D Ko, C Oromendia, R Scher, SR Lipner Journal of the American Academy of Dermatology 80 (5), 1272-1283, 2019 | 42 | 2019 |
| Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy WG Jackson, C Oromendia, O Unlu, D Erkan, MT DeSancho Blood advances 1 (25), 2320-2324, 2017 | 40 | 2017 |
| Circulating RIPK3 levels are associated with mortality and organ failure during critical illness KC Ma, EJ Schenck, II Siempos, SM Cloonan, EJ Finkelzstein, MA Pabon, ... JCI insight 3 (13), 2018 | 37 | 2018 |
| Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis EJ Schenck, KC Ma, DR Price, T Nicholson, C Oromendia, ER Gentzler, ... JCI insight 4 (9), 2019 | 35 | 2019 |
| Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort WZ Zhang, MC Rice, KL Hoffman, C Oromendia, IZ Barjaktarevic, ... JCI insight 5 (3), 2020 | 33 | 2020 |
| Prognostic significance of digital rectal examination and prostate specific antigen in the prostate, lung, colorectal and ovarian (PLCO) cancer screening arm JA Halpern, JE Shoag, S Mittal, C Oromendia, KV Ballman, DL Hershman, ... The Journal of Urology 197 (2), 363-368, 2017 | 29 | 2017 |
| Prognostic significance of a negative prostate biopsy: an analysis of subjects enrolled in a prostate cancer screening trial P Lewicki, J Shoag, DM Golombos, C Oromendia, KV Ballman, ... The Journal of Urology 197 (4), 1014-1019, 2017 | 22 | 2017 |
| A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC) H Beltran, D Danila, B Montgomery, R Szmulewitz, U Vaishampayan, ... Annals of Oncology 27, vi565, 2016 | 20 | 2016 |
| Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS WZ Zhang, C Oromendia, SA Kikkers, JJ Butler, S O’Beirne, K Kim, ... Scientific reports 10 (1), 10562, 2020 | 19 | 2020 |
| Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation LK Torres, KL Hoffman, C Oromendia, I Diaz, JS Harrington, EJ Schenck, ... Thorax 76 (12), 1176-1185, 2021 | 18 | 2021 |
| Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series JC van der Mijn, B Al Hussein Al Awamlh, A Islam Khan, ... PloS one 14 (12), e0226285, 2019 | 17 | 2019 |
| Changes in practice patterns in male infertility cases in the United States: the trend toward subspecialization PV Bach, N Patel, BB Najari, C Oromendia, R Flannigan, R Brannigan, ... Fertility and Sterility 110 (1), 76-82, 2018 | 17 | 2018 |
